Abstract
Patients with multiple sclerosis (MS) disease frequently experience fatigue as their most debilitating symptom. Fatigue in MS partially refers to a cognitive component, cognitive fatigue (CF), characterized by a faster and stronger than usual development of the subjective feeling of exhaustion that follows sustained cognitive demands. The feeling of CF might result from supplementary task-related brain activity following MS-related demyelination and neurodegeneration. Besides, CF in MS disease might also stem from disrupted sleep. The present study investigated the association between the triggering of CF, task-related brain activity and sleep features. In a counterbalance mixed design, 10 patients with MS and 11 healthy controls were exposed twice for 16 min to a CF-inducing dual working memory updating task (TloadDback) under low or high cognitive demands conditions, counterbalanced. Considering known inter-individual differences and potential cognitive deficits in MS, the maximal cognitive load of the task was individually adapted to each participant’s own upper limits. During the experimental sessions, cortical brain activity was measured using near-infrared spectroscopy (NIRS) during the CF-induction task, and in a resting state immediately before and after. Ambulatory polysomnography recordings were obtained on the nights preceding experimental sessions. When cognitive load was individually adapted to their processing capabilities, patients with MS exhibited similar than healthy controls levels of subjectively perceived CF, evolution of performance during the task, and brain activity patterns. Linear mixed models indicate a negative association between oxygenation level changes in the dorsolateral prefrontal cortex (DLPFC) and the triggering of subjective CF in patients with MS only. Longer total sleep time was also associated with higher CF in MS patients. These results suggest that controlling for cognitive load between individuals with and without MS results in a similar task-related development of subjective CF. Besides comparable performance and cortical brain activity between groups, mixed model analyses suggest a possible association between CF, DLPFC activity and sleep duration in MS disease.
Introduction
Multiple sclerosis (MS) is a neurodegenerative disease characterized by inflammation, demyelination and axonal degeneration, often accompanied by motor and cognitive deficits (Trapp et al., 1998). MS is the first cause of disability in young populations in modern societies (Rosati, 2001), with high social care costs (). Fatigue is the most common symptom, reported by up to 90% of patients with MS (Walker et al., 2012). Moreover, fatigue is for more than half of the patients reported as the main cause of interference with daily living activities and quality of life (). Multifactorial in nature, the phenomenon can be classified into primary fatigue, if the causal mechanisms are directly related to the disease, and secondary fatigue, if the mechanisms are not specific to the disease (). Primary fatigue has been associated with brain atrophy (; ), functional brain connectivity changes (; ), disease severity (Pittion-Vouyovitch et al., 2006) as usually assessed with the Expanded Disability Status Scale (EDSS; ), dopamine imbalance (), neuroendocrine level variations (e.g., pro-inflammatory cytokines; ) and compensatory brain overactivation patterns (; Leocani et al., 2008). For its part, secondary fatigue has been associated with factors such as mood and personality (), depression (Strober and Arnett, 2005) or sleep disturbances (Veauthier and Paul, 2014). In spite of the large number of variables associated with fatigue, the symptom is still barely understood, and pharmacological treatments are barely efficient (). One potential explanation for inconclusive results might stem from a lack of specification of the term “fatigue.” Indeed, the physical, cognitive and psychosocial aspects of fatigue are often intermixed during the assessment of the symptoms. For instance, these different aspects are not explicitly segregated in the most popular fatigue severity scale inventory (FSS; ). Physical and cognitive fatigue (CF) are better distinguished in the fatigue scale for motor and cognitive functions (FSMC; Penner et al., 2009), but fatigue is only assessed as a trait in this scale. However, patients with MS experience variations in their fatigue state in daily life, and might be especially vulnerable to CF triggered online by task-related cognitive demands. Although several studies might support the assumption that CF develops faster in patients with MS than in controls (Lehmann et al., 2012; ; Sandry et al., 2014), it is worth noticing that in these studies, all participants were exposed to the same task conditions, which might bias the evaluation of CF. Indeed, since attentional (Urbanek et al., 2010) and working memory () deficits are often reported in MS, cognitive demands for the same task conditions are likely to be much higher for patients than controls, thus eventually leading to higher pressure and CF levels. Therefore, to delineate the development of task-related CF in MS disease from other factors, task demands should be carefully adapted to each patient’s individual cognitive processing capacity.
As mentioned above, compensatory cortical overactivity needed to maintain performance at normal levels in visual (Werring et al., 2000; ), motor (Pantano, 2002; Tomassini et al., 2012) and cognitive (; ; ) tasks is viewed as a potential cause for CF in MS disease. Besides, it was proposed that compensatory brain overactivity required to cope with the neurodegenerative process in MS is a cause of acute fatigue (Leocani et al., 2008). However, evidence remains scarce (; ) and no predictors of this capacity have been described beyond cognitive reserve (; ). Additionally, sleep disturbances have been reported in MS, and especially fragmented sleep (). Sleep is involved in brain plasticity maintenance () and is hypothesized to support the cellular homeostasis restorative processes allowing the brain to cope with daily cognitive challenges (Tononi and Cirelli, 2014). Thus, sleep fragmentation in MS might reduce the efficacy of brain compensatory mechanisms to maintain performance, eventually resulting in a faster triggering of CF. If this relation is proven true, then sleep medicine interventions in the clinical management might contribute to improve quality of life in MS patients.
In this framework, we aimed at investigating the putative triangular relationship between the triggering of CF, cortical overactivity patterns and sleep disruptions. To assess CF unbiased by interindividual differences face to the same task conditions, we used a paradigm in which task-related cognitive load can be individually adapted to each participant’s maximal performance level (TloadDback task; ). Participants were then administered in a counterbalanced design the same task on two separate occasions, once in a high cognitive load (HCL) and once in a low cognitive load (LCL) condition. Cortical activity was recorded before, during and after the CF-inducing task (HCL and LCL on two separate days) using functional near infrared spectroscopy (fNIRS). Polysomnography recordings were obtained for the nights preceding each of the experimental days.
Materials and Methods
Participants
Ten patients with relapsing-remitting MS (RRMS) according to the criteria of McDonald et al. (2001) and 11 healthy controls were included in the present study. Patients were recruited over a 12-month period by an experienced neurologist (AL), and were in remission from the time of the clinical examination until the NIRS imaging session. All participants gave their written informed consent to participate in the present study conducted in agreement with the Declaration of Helsinki, and approved by the institutional ethics committee of the ULB-Erasme Hospital. MS and control groups had similar level of education (in years) but were not matched for age (Table 1). Therefore, age was included as a confounding covariate in the statistical analyses. Demographic and neuropsychological data are reported in Table 1. Due to a data transfer problem, fNIRS data were not accessible for two patients. Likewise, PSG was not obtained in one MS patient and one control participant, due to bad quality in the EEG signal.
Table 1
| Healthy controls (n = 11) | Patients with MS (n = 10) | p/BF | p/(age as covariate)/BF | ||
|---|---|---|---|---|---|
| Age | 34.18 ± 4.64 | 42.1 ± 7.1 | <0.05/>7∗ | – | |
| Disease duration (years) | – | 7.6 ± 5.9 | – | – | |
| Last manifestation (years) | – | 3.44 ± 3.4 | – | – | |
| EDSS (range) | – | 1.65 ± 0.77 (0-3) | – | – | |
| Years of education | 15.64 ± 1.9 | 14.1 ± 2 | >0.081/1.2 | >0.16/0.6 | |
| Depression | 3 ± 2.7 | 5.2 ± 3.2 | >0.1/1.1 | <0.1/1.2 | |
| Anxiety | 4.7 ± 2.1 | 7.1 ± 2.6 | <0.05∗/2.2 | >0.18/1.6 | |
| sleep | /PSQI | 4.2 ± 1.7 | 7.6 ± 3.2 | <0.01/4∗ | <0.05/>3∗ |
| /H&S | 49.3 ± 8.6 | 55.9 ± 12.5 | >0.17/0.8 | >0.79 /0.6 | |
| FSMC | / cognitive | 22 4 ± 6 8 | 32.1 ± 7 | <0.005/9∗ | <0.05/12∗ |
| / physical | 21 2 ± 8.2 | 36 ± 4.6 | <0.001/252∗ | <0.001/170∗ | |
| / psychosocial | 4.7 ± 1.8 | 6.6 ± 1.8 | <0.05∗/2.4 | >0.49/1.2 | |
| Digit Spandirect | 70 ± 3% | 54 ± 17% | <0.05/>3∗ | >0.24/1 | |
| Digit Spaninverse | 54 ± 18% | 46 ± 15% | >0.23/0.6 | >0.31/0.6 | |
| Visual Spandirect | 76 ± 4% | 64 ± 11% | <0.05∗/2.4 | <0.05∗/2.3 | |
| Visual Spaninverse | 73 ± 20% | 61 ± 12% | <0.05∗/2.5 | <0.05∗/2.7 | |
| TMTNumbers Sequencing | 22 ± 2.7 s | 27 ± 10 s | <0.05∗/2.3 | >0.15/1.7 | |
| TMTSwitching | 51 ± 23 s | 66 ± 40 s | <0.05/>3∗ | <0.06/2.8 | |
| Stroop Inhibition | 85 ± 14 s | 110 ± 18 s | <0.005/13∗ | <0.005/17∗ | |
| SDMTa | 66 ± 15 | 53 ± 6 | <0.05/>3∗ | <0.05/8∗ | |
| PASAT-3sb | 46 ± 8 | 38 ± 12 | =0.09/1.3 | <0.005∗/14 | |
| PASAT-2sb | 36 ± 11 | 25 ± 11 | <0.05∗/2.9 | <.005/3.9∗ | |
Demographic and neuropsychological data in healthy controls and patients with MS disease.
Values are mean and standard deviation (m ± std). P-values, computed using non-parametric Mann–Whitney tests/Bayes factors (BF) are provided on the 3rd and 4th columns. BFs < 0.33 suggest equality between H0 and H1 and BFs > 3 inequality. Values in between [0.33 – 3] denote inconclusive results. EDDS, Expanded Disability Status Scale (), an universal scale to rate neurologic impairment in multiple sclerosis. aIn number of identified and written elements. bNumber of correct responses. ∗New ANCOVA p-values with age as covariate are displayed on right column. Statistically significant values are highlighted in bold font.
Experimental Design and Procedure
The experiment was carried out over 7 consecutive days (Figure 1). On Day 1, a Pretest session (35–40 min duration) aimed at determining for each participant separately her/his maximal cognitive load capacity on the CF-inducing TloadDback task (see below). I.e., maximal load was defined as the fastest stimulus presentation rate at which the participant was still able to maintain an accuracy performance > 85%. This fastest presentation rate defined the HCL condition. For the LCL condition, stimulus presentation rate was slowed down by 50%, making it easier to process the ongoing stimuli. This procedure was shown efficient to induce high vs. low levels of CF in healthy participants (, ). Following the Pretest session at Day 1 and after a brief rest period (∼ 10 min), a neuropsychological battery test (average duration 45 min) was administered. On Day 5 and Day 7, participants were first equipped with the fNIRS optodes (20–25 min), and then administered during 16 min the TloadDback task under either the high (HCL) or the low (LCL) cognitive load condition, in a counterbalanced order. Cortical activity was recorded using fNIRS during the 16 min of TloadDback task practice, and during two 4-min resting state (Rst1) sessions, immediately before and after the TloadDback task. In the resting state sessions, participants were asked to look at a fixation cross on a computer screen. Before and after each resting state and the TloadDback task (i.e., at 4 time points per testing day, see Figure 1), participants were asked to report their subjectively perceived levels of CF and sleepiness using visual analog scales Thus, a whole testing session lasted approximately for 50 min. The night before each testing session, sleep was recorded using ambulatory polysomnography at the participant’s home. Polysomnography was set-up and configured by the principal investigator (GB) 1–2 h before participants’ usual bedtime. To prevent circadian confounds, all testing sessions took place at the same time of day within each participant, either in the morning (9–12 h) or in the afternoon (14–19 h).
FIGURE 1
Tasks and Material
Cognitive Fatigue Induction Paradigm (TloadDback)
Cognitive fatigue was induced using the TloadDback task (for details see ), a dual task that combines a working memory updating task (N-back; ) and a parity number decision task. In this task, digits and letters are displayed on screen in alternation. Participants are instructed to press the space bar with their left hand every time the displayed letter is the same than the penultimate letter, or to indicate whether the displayed digit is odd or even by pressing “1” or “2” on the numeric keypad. Combining two tasks featuring different processing requirements ensures a large recruitment of working memory resources, eventually leading to a decrease in performance and the intensification of the subjective feeling of mental exhaustion (). The task includes a separate pretest session (on Day 1) during which the individual’s maximal cognitive load capacity is determined as the shortest duration the stimuli can be presented (stimulus time duration; STD) for a performance still > 85% accuracy. During this pre-test session, STD was initially set at 1500 ms for the first block (30 letters and 30 digits, alternating), then speeded up by 100 ms for the next block if accuracy performance was >85%. The procedure was repeated until accuracy performance dropped < 85%, indicating that the participant’s cognitive load limit had been reached. STD was then slowed down by 100 ms, and again speeded up by 100 ms in case of success, to improve the reliability in the pre-test. After three failures to reach accuracy > 85% at a given STD, the immediately preceding STD at which performance was still successful was determined as the individual’s maximal capacity, which was used in the testing session to define the HCL condition. For the LCL condition, STD was made longer by 50%, eventually ensuring comparable levels of low vs. high cognitive demands between individuals. CF was assessed subjectively using a Visual Analog Scale for fatigue (VASf: Lee et al., 1991), and objectively by computing the evolution of performance (accuracy) across four 4-min quartiles (i.e., t1, t2, t3, and t4) during the 16 min duration of the TloadDback task. Additionally, self-reported sleepiness was assessed using a VAS scale (VASs).
Neuropsychological Battery
Executive function and information processing capacities were evaluated using several neuropsychological tests (French versions). The digit and visual spans of the Wechsler Adult Intelligence Scale (WAIS; Wechsler, 1981) consist on a verbal repetition of numbers (Digit) or spatial positions (Visual) in direct and reverse order; they are usually employed to assess short-term and working memory functioning. The Trail-Making Test (Reitan, 1958) mostly tests mental flexibility. It features 25 circles distributed over a sheet. In the Numbers Sequencing condition, the circles are numbered 1 – 25 and the individuals must draw lines to connect the numbers in ascending order. In the Switching Part condition, the circles include both numbers (1 – 13) and letters (A – L) and the individuals must connect the circles alternating numbers and letters in ascending order again (i.e., 1-A-2-B-3-C, etc.). Successful TMT performance requires adequate letter and number recognition, mental flexibility, visual scanning and motor function (). In the Stroop task (Stroop, 1935), participants are asked to provide the ink color of a written color name. Interference due to automatic reading makes providing the ink color more difficult and slower when the written color name is different from the printed color. The test thus assess the inhibitory component of selective attention and processing speed ability (Lamers et al., 2010). The written section of the Symbol Digit Modalities Test (SDMT; Smith, 1968) requires individuals to identify nine different symbols corresponding to the numbers 1 through 9 and to manually fill the blank space under each symbol with the corresponding number, as fast as possible. The final score is computed as the number of correct symbols identified and written down in a 90 s interval. The neuropsychological assessment ended up with the Paced Auditory Serial Addition Test (PASAT; ). In this test, single digits are presented either every 3 (trial 1) or 2 (trial 2) seconds, and individuals must add each new digit to the one immediately prior to it. Final score is the total number of correct sums given (out of 60 possible) in each trial. The test is widely employed in MS disease to evaluate processing speed, flexibility and calculation ability (Rudick et al., 1997). To moderate the cognitive workload caused by neuropsychological assessment, tests were administered in the order in which they are described in the text.
Polysomnography
To investigate sleep characteristics in the nights preceding the behavioral and fNIRS imaging sessions, we used ambulatory polysomnography (BrainRT EEG/PSG system, OSG BVBA, Belgium). PSG recording included standard electroencephalogram (EEG) at locations Fp1, Fp2, F3, F4, C3, C4, P3 and P4 according to the standard 10–20 system, electrooculogram (EOG), electromyogram (EMG), and electrocardiogram (ECG). Respiratory events were detected using abdominal and thoracic belts, oral/nasal airflow with a nasal pressure transducer, an oronasal thermocouple and oxygen saturation levels measured by finger pulse oximetry. PSG scoring was performed in agreement with the American Academy of Sleep Medicine (AASM) criteria (). Each 30-s epoch was visually classified by a qualified expert somnologist (MG) as Wake, N1, N2, N3 or REM sleep stage. Sleep onset was defined as the first 30-s epoch scored N2, SWS or REM and final awakening as the last 30-s epoch scored N2, SWS or REM. Sleep period time was defined as the time interval separating sleep onset from final awakening. Total sleep time was calculated as the sleep period time minus the duration of intra-sleep awakenings, and sleep efficiency was expressed as the percentage of total sleep time during the sleep period time. The apnoea-hypopnea index (AHI) was computed in all participants. The cut-off score for the presence of apnoea was AHI > 5 events per hour. Micro arousals were computed as awakening periods > 3 s and <15 s. EEG data were visualized using the PRANA software package (PhiTools, Strasbourg, France).
fNIRS Acquisition
Variations in haemodynamic cortical activity were recorded using a multichannel fNIRS system (BrainSight, V2.3b16, NIRS, Rogue Research Inc., Canada) with two continuous wavelengths (685 and 830 nm). The set-up featured a total of 24 channels (detectors) created around 6 source optodes encompassing 3 areas in each cerebral hemisphere: ventrolateral prefrontal cortex (VPFC), dorsolateral prefrontal cortex (DLPFC), and Inferior Parietal Cortex (IPC). Channels in each area were averaged to provide a general measure of brain activity. Optodes were positioned and located using a 3-D coordinates system combined with a Polaris localization device (see Figure 2). Channels displacements during the experiment were minimized using elastic tape. Detector optodes were located at an approximate distance of 3 cm from the source optodes. Functional NIRS signals were recorded at a sample rate of 20 Hz. To limit the natural trend appearing within signal recording, separate recordings were made for the Rst1, TloadDback and Rst2 periods. This made also easier to remind the TloadDback task instructions. Thus, there is a short temporal gap between the 3 successive recordings conducted within one individual.
FIGURE 2
fNIRS Analysis
Oxyhemoglobin ΔHbO and deoxyhemoglobin ΔHbR were computed at each time point for each channel using the modified Beer–Lambert law. For each participant, raw recorded absorption units were normalized then low-pass filtered (0.009 – 0.08 Hz) to attenuate high-frequency noises arising from Mayor waves: respiration, cardiac pulsations and optodes movements. Furthermore, to improve signal quality, noisy channels were automatically detected and removed from the analysis using an automated algorithm based on correlation analysis (
The fNIRS signal was analyzed computing two different indicators of brain activity. First, cortical activity changes during practice of the TloadDback task and during resting states were estimated computing Cerebral Oxygen Exchange (COE; see e.g., Sano et al., 2013; Yoshino et al., 2013), an indirect measure of brain metabolism computed as the difference between HbR and HbO. Higher COE indicates reduced oxygenation levels, and vice-versa. Task-related changes in brain activity during the ensuing resting state period (Rst) were estimated by computing the amplitude of low frequency fluctuations (ALFF; Yu-Feng et al., 2007) of the total hemoglobin concentration. ALFF is viewed as a good measure of spontaneous neural activity, appropriate to detect state-dependent resting brain changes associated with CF (
Statistics
Statistical analyses were computed following
Results
Demographic parameters and results on neuropsychological tests are provided Table 1. MS patients were significantly older than controls (p < 0.05, Bayes factor [BF] > 3). For this reason, age was considered as a covariate in the subsequent analyses. When considering the covariate age, sleep quality as measured through the PSQI was lower (p < 0.05, BF > 3) and levels of cognitive and physical fatigue higher (p < 0.05, BFs > 3) in MS patients compared to healthy controls. Besides, patients’ performance was lower in both direct and indirect visual span tests (p < 0.05, BFs = inconclusive), the Stroop task (p < 0.01, BF > 17), the SDMT (p < 0.05, BF > 8) and the PASAT-3s (p < 0.01, BF = inconclusive) and PASAT-2s (p < 0.01, BFs > 3).
Behavioral Data
Pretest
First, we investigated between-group differences in the optimal stimulus time duration (STD) needed to maintain successful performance (accuracy > 85%) in the TloadDback task at Pretest on Day 1. An ANCOVA performed on the STD with a between-subject factor Group and the confound covariate Age disclosed significant differences [F(1,18)= 5.78; p < 0.05; MSE = 0.23; = 0.24]. Participants in the control group had a shorter (faster) STD (average ± standard deviation 811 ± 0.094 ms) than participants with MS (960 ± 126 ms).
Self-Reported Evolution of Cognitive Fatigue and Sleepiness (VAS)
Subjective evolution of CF was assessed using the VASf before (p1) and after (p2) the resting state session Rst1, after the TloadDback task (p3) and after resting session Rst2 (p4), see Figure 3. A mixed repeated-measure ANCOVA was computed on VASf scores with within-subject factors Condition (HCL vs. LCL) and Period (p1 vs. p2 vs. p3 vs. p4), between-subjects factor Group (Healthy controls vs. MS patients) and confounding covariate Age. Results disclosed a triple interaction Condition × Period × Group [F(3.51)= 3.56; p < 0.05; MSE = 0.97; = 0.17; BF was < 0.33]. Tukey post hoc tests showed that CF similarly increased in both groups in the LCL condition (all p < 0.88) with significant differences found between p1- p3 and p1- p4 for both groups (all p < 0.05), i.e., from before the pre-task resting state session (p1) to after the TloadDback (p3) and after the post-task resting state session (p4). CF was not significantly modified from immediately before (p2) to immediately after (p3) the TloadDback task in the LCL condition (all p > 0.16). In the HCL condition, CF increased in both groups (all p < 0.54) with significant differences found again between p1 – p3 and p1 – p4, but also from immediately before the task to immediately after (p2 – p3) and to after the second resting state session (p2 – p4), in both groups (all p < 0.05). Finally, CF significantly increased in MS patients from the pre- (p1) to the post- (p2) resting state session Rst1 (p < 0.05), i.e., before exposure to the CF-inducing TloadDback task. This effect was not present in healthy controls (p > 0.9).
FIGURE 3

Evolution of self-reported cognitive fatigue (CF) using visual analog scales for fatigue (VASf). HCL: high cognitive condition; LCL: low cognitive condition; Rst: pre- (Rst1) and post- (Rst2) task resting state sessions (5 min); TloadDback: CF-inducing dual task (16 min). The interaction between Condition (HCL vs. LCL), Period (pre-Rst1 p1, pre-TloadDback p2, post-TloadDback p3, post-Rst2 p4) and Group (Healthy controls vs. MS patients) was significant (p < 0.05). Asterisks indicate significant p-values after Tukey post hoc correction: ∗p < 0.05; ∗∗p < 0.01, and ∗∗∗p < 0.001. n.s, non-significant.
Similar analyses computed on sleepiness scores failed to disclose any significant effects (all p > 0.16; all BFs < 0.033).
TloadDback
Accuracy performance during the 16 min practice on the TloadDback task was computed across four successive 4-min quartiles (t1, t2, t3 and t4; see Table 2), and entered in a mixed repeated-measure ANCOVA with within-subject factors Condition (HCL vs. LCL) and Time (t1 vs. t2 vs. t3 vs. t4), between-subjects factor Group (Healthy controls vs. MS patients) and confound covariate Age. The triple interaction Condition × Time × Group did not reach significance (p > 0.1, BF < 0.33). There was, however, a main Condition effect [F(1,18)= 20.76; p <0.001; MSE = 0.003; = 0.54; BF > 100] with higher performance in the LCL (95.2 ± 3.5%) than in the HCL (86.7 ± 6.3%) condition. The Condition × Group interaction was also significant [F(1,18)= 8.1; p <0.05; MSE = 0.003; = 0.31; BF = 0.64], but Tukey post hoc tests failed to disclose between-groups differences in performance either in the LCL (Controls 95.5 ± 3.5% vs. MS 95 ± 3.6%) or the HCL (Controls 88 ± 6.3% vs. MS 85 ± 6.3%) condition (all p > 0.6). There was also a significant covariate effect of Age on Condition [F(1,18)= 10.1; p <0.01; MSE = 0.003; = 0.36].
Table 2
| TloadDback task | |||||
| Group | Condition | t1 | t2 | t3 | t4 |
|---|---|---|---|---|---|
| Healthy Controls | HCL | 90,40 ± 1.9 | 89,82 ± 2.2 | 86,56 ± 2.9 | 85,56 ± 3.3 |
| LCL | 95,96 ± 0.9 | 96,14 ± 1.3 | 94,54 ± 1.5 | 95,24 ± 1.2 | |
| MS patients | HCL | 84,65 ± 2.3 | 85,39 ± 1.8 | 84,65 ± 1.7 | 86,83 ± 1.8 |
| LCL | 95,86 ± 1.1 | 94,38 ± 1.6 | 94,09 ± 1.8 | 95,57 ± 0.7 | |
Evolution of accuracy performance across the four quartiles (t1 to t4) during the TloadDback by Condition (HCL vs. LCL) and Group (Controls vs. MS patients).
Analyses did not reach significance (p > 0.13; BF < 0.33).
fNIRS Results
CF-Induction Related COE During Task Practice
As a reminder, COE values were computed across four successive 4-min quartiles (t1, t2, t3, and t4) for each of the 6 target areas (3 per hemisphere), and entered in a repeated-measure ANCOVA with within-subject factors Area (VLPFC vs. DLPFC vs. IPC), Hemisphere (Right vs. Left), Time on Task (ToT; t1 vs. t2 vs. t3 vs. t4) and Condition (HCL vs. LCL), between-subjects factor Group (Healthy controls vs. MS patients), and confound covariate Age. No significant effect was found (all p > 0.15).
CF-Induction Related COE During Pre- and Post-task Resting States
COE values were similarly recorded for each of the 6 target areas (3 per hemisphere) during the resting states immediately before and after the TloadDback task. A repeated-measure ANCOVA was conducted on COE values during Rst periods with within-subject factors Area (VLPFC vs. DLPFC and IPC), Hemisphere (Right vs. Left), Condition (HCL vs. LCL) and Resting State (pre Rst1 vs. post Rst2), between-subjects factor Group (Controls vs. MS patients) and confounding covariate Age. All effects were non-significant (all p > 0.07).
CF-Induction Related ALFF During Pre- and Post-task Resting States
The Amplitude of Low Frequency Fluctuations (ALFF) is an index of spontaneous neural activity sensitive to activity changes during resting state sessions (Yu-Feng et al., 2007). A repeated-measure ANCOVA was conducted on ALFF values with within-subject factors Area (VLPFC vs. DLPFC and IPC), Hemisphere (Right vs. Left), Condition (HCL vs. LCL) and Resting State (pre Rst1 vs. post Rst2), between-subjects factor Group (Healthy controls vs. MS patients) and confounding covariate Age highlighted an Area × Group interaction effect [F(2,26)= 4.9; p <0.05; MSE = 0.003; = 0.14; BF = 0.27]. Tukey post hoc disclosed lower ALFF in IPC than VLPFC and DLPFC both in Controls (p < 0.005) and MS patients (p < 0.001). Separate ANCOVA in each region of interest failed to disclose significant effects in the VLPFC (all p > 0.20), the DLPFC (all p > 0.32) and the IPC (all p > 0.27).
Sleep Architecture
To investigate possible structural differences in sleep patterns between patients with MS and Controls (as previously reported, e.g.,
Table 3
| Healthy controls (n = 10) | Patients with MS (n = 9) | p (age as covariate)/BF ± | |
|---|---|---|---|
| Total Sleep Time (TST; min) | 391.7 ± 60.7 ± | 380.8 ± 55.5 | >0.77/0.43 ± |
| Sleep Efficiency (TST/SPT) | 92.6 ± 6.8 ± | 89.4 ± 15.4 | >0.91/0.45 ± |
| Stage N1 (% TST) | 6.4 ± 3.6 ± | 5.5 ± 2 | >0.76/0.56 ± |
| Stage N2 (% TST) | 50 ± 6.1 ± | 52 ± 8.5 | >0.53/0.46 ± |
| Stage N3 (% TST) | 16.6 ± 5.4 ± | 17.3 ± 5.5 | >0.36/0.45 ± |
| Stage REM (% TST) | 26.7 ± 9.5 ± | 25 ± 4.5 | >0.94/0.44 ± |
| Number of ISA (>2 min) | 4 ± 2.3 ± | 2.5 ± 1.3 | >0.1/1.2 ± |
| ISA duration (min) | 34.7 ± 23.3 ± | 37.3 ± 41.1 | >0.76/0.41 ± |
| Arousal index (/h) | 2.2 ± 2.3 ± | 4.7 ± 3.5 | <0.05∗/1.2 ± |
| Number of Microarousal | 15.3 ± 7.6 ± | 17.2 ± 4.7 | >0.91/0.45 ± |
| Duration of Microarousal (min) | 6.3 ± 0.8 ± | 6.6 ± 0.8 | >0.54/0.54 ± |
| Number of Hypoapnea | 0.5 ± 1.2 ± | 1.3 ± 1.9 | >0.76/0.05 ± |
| Duration of Hypoapnea | 3.8 ± 7.16 ± | 9.1 ± 11.4 | >0.77/0.51 ± |
| Number of Central Apnea | 0.05 ± 0.16 ± | 0 ± 0 | >0.67/0.55 ± |
| Duration of Central Apnea | 0.9 ± 2.8 ± | 0 ± 0 | >0.69/0.54 ± |
| Obstructive Apnea (OSA) | 0 ± 0 ± | 0.4 ± 0.9 | >0.44/0.79 ± |
| Duration of Obstructive Apnea | 0 ± 0 ± | 7.6 ± 18.6ˆ* | >0.69/0.62 ± |
Polysomnography results.
Values are mean and standard deviation (m ± std). TST, Total sleep time; SPT, Sleep period time; ISA, Intra sleep awakening. P-values are regular/Bayesian ANCOVAs with age as covariate. ∗To note that the duration of OSAs is below 10 s because it represents the average duration among patients; only two of them presented two respiratory events classified as OSA (An apnea must last more than 10 s to be classified as obstructive;
Relationship Between Cognitive Fatigue, Brain Activity and Sleep
Finally, we investigated the potential dual relatioship between the triggering of CF, brain activity patterns and sleep architecture, using three different multiple regression models with between-subjects factor Group (Controls vs. MS patients) and confounding covariate Age. Again, given the restricted sample size, relevant values (self-reported feelings of CF, brain activity and sleep parameters) were averaged over the two sessions to reduce the loss of statistical power due to the inclusion of a new factor in the modeling. Predictors were centered and outliers excluded before computing the analyses.
Model A. Relationship Between Brain Activity and Triggering of CF (N Controls = 10; N MS patients = 8)
The first model aimed at investigating the relationship between the COE in the three regions of interest (ROIs: VLPFC, DLPFC, IPC) included in the fNIRS set-up (calculated as the average values of COE during TloadDback in both HCL and LCL conditions) and the feeling of CF triggered as a consequence of performing in the TloadDback (i.e., average of self-reported CF during HCL and LCL conditions). COE values at the three ROI were initially included as predictors of CF. Nevertheless, the variance inflation factor (VIF) of the model revealed the existence of collinearity among the predictors (all VIFs > 0.7). Therefore, we computed three explorative regression models for each predictor. Models with COE activity in IPC and VLPFC as predictors did not show any significant result (all p> 0.1). At variance, COE activity in the DLPFC region exhibited a significant interaction by group (Figure 4A), suggesting that activity in this area was associated to the triggering of CF only in MS patients (p < 0.005; Adjusted R squared > 42% variance). The beta of the slope for the Healthy controls group was -1,7e05 whereas for the group of MS patients it was 6.2e05.
FIGURE 4

(A) Scatterplot illustrating the association between self-reported feelings of cognitive fatigue (CF; VASf) and DLPFC activity (COE). (B) Scatterplot between self-reported feelings of CF and total sleep time on the preceding night.
Model B. Relationship Between Sleep Parameters and the Triggering of CF (N Controls = 10; N MS patients = 9)
Given the large number of potential sleep predictors (
Model C. Relationship Between Sleep Parameters and CF-Related Brain Activity (N controls = 9; N MS patients = 7)
A new model was created to investigate a possible association between the sleep parameters previously defined and the levels of COE activity in the 3 ROIs. Results failed to disclose significant differences (all p > 0.1).
Discussion
The purpose of the present study was to investigate cortical brain activity and sleep architecture as possible explanatory factors for the triggering of CF in MS disease. To induce comparable levels of CF between healthy controls and MS patients, we used a task that allows adapting cognitive demands to each participant’s optimal performance levels (and cognitive load) during a pretest session (
Although the authors acknowledge that a limited sample size in this study asks for caution in the interpretations, Bayesian analyses confirmed an absence of differences in task performance and sleepiness evolution. Moreover, the differential evolution of CF was observed over all the experiment, and was apparently not driven by cognitive load exposure, as patients with MS increased CF within the 5 min of the first resting state session, that is even before the administration of the CF-inducing task. Overall higher fatigability in MS patients was reported in the literature, and might result from the influence of external variables such as anxiety, depression or sleep disorders (lriarte et al., 2000). Notwithstanding those reservations, regression models evidence potential associations between the subjective triggering of CF, brain activity and sleep.
The first regression model disclosed a direct relationship, only present in patients with MS, between brain activity in the DLPFC region and the triggering of subjective CF during the TloadDback task. Diminished oxygenation levels (i.e., higher COE) in the DLPFC were associated with higher feelings of CF. This result may corroborate recent evidence (Sepulcre et al., 2009;
The second regression model evidenced an association between self-reported CF and total sleep time, again only in patients with MS. The analysis suggests that participants who sleep more presented a higher sensitivity to the triggering of CF. That MS patients sleeping longer experience a faster triggering of CF might be explained from two different perspectives. First, it might suggest that patients need longer sleep periods to recover from daytime activity because their sleep is less efficient. Although this possibility was previously discussed (
Finally, we are willing to acknowledge limitations in our study linked to reduced sample size, and hence reduced statistical power. Nevertheless, the robust nature of our intra-subject comparison models substantiated by Bayesian evidence emphasize the importance of considering individual differences in cognitive capacity prior to the assessment of CF, especially when clinical group are investigated. Besides, mixed models provide further evidence linking cortical brain activity, sleep and CF in MS disease.
Statements
Author contributions
GB: substantial contributions to acquisition, analysis, interpretation, and drafting and revising of last version to be published. MG: substantial contributions to the analysis of polysomnography recordings. AA: substantial contributions to the statistical analysis. HS: substantial contributions to data acquisition and interpretation of the data. AL: substantial contributions to patient’s recruitment. MDS: substantial contributions to data acquisition. PP: substantial contributions to acquisition, analysis, interpretation, and drafting and revising of last version to be published.
Funding
GB was supported by the Program P7/33 IPA/PAI COOL. MG is FRS-FNRS Research Fellow. PP is Francqui Research Professor 2013–2016. The NIRS equipment was supported by FRS-FNRS “Grands Equipements” Fund 2.5020.12.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer MMuthalib and handling Editor declared their shared affiliation.
References
1
AastedC. M.YücelM. A.CooperR. J.DubbJ.TsuzukiD.BecerraL.et al (2015). Anatomical guidance for functional near-infrared spectroscopy: atlasviewer tutorial.Neurophotonics2:020801. 10.1117/1.NPh.2.2.020801
2
AdelmanG.RaneS. G.VillaK. F. (2013). The cost burden of multiple sclerosis in the United States: a systematic review of the literature.J. Med. Econ.16639–647. 10.3111/13696998.2013.778268
3
AudoinB.ReuterF.DuongM. V. A.MalikovaI.Confort-GounyS.CherifA. A.et al (2008). Efficiency of cognitive control recruitment in the very early stage of multiple sclerosis: a one-year fMRI follow-up study.Mult. Scler.14786–792. 10.1177/1352458508089360
4
BerryR. B.BudhirajaR.GottliebD. J.GozalD.IberC.KapurV. K.et al (2012). Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events.J. Clin. Sleep Med.8597–619. 10.5664/jcsm.2172
5
BolY.DuitsA. A.HuppertsR. M. M.VlaeyenJ. W. S.VerheyF. R. J. (2009). The pychology of fatigue in patients with multiple sclerosis: a review.J. Pychosom. Res.663–1110.1016/j.jpsychores.2008.05.003
6
BonnetM. C.AllardM.DilharreguyB.DeloireM.PetryK. G.BrochetB. (2010). Cognitive compensation failure in multiple sclerosis.Neurology751241–1248. 10.1212/WNL.0b013e3181f612e3
7
BorragánG.SlamaH.BartolomeiM.PeigneuxP. (2017). Cognitive fatigue: a time-based resource-sharing account.Cortex8971–84. 10.1016/j.cortex.2017.01.023
8
BorragánG.SlamaH.DestrebecqzA.PeigneuxP. (2016). Cognitive fatigue facilitates procedural sequence learning.Front. Hum. Neurosci.10:86. 10.3389/fnhum.2016.00086
9
BrissartH.LeiningerM.Le PerfM.TaillemiteL.MoreleE.DebouverieM. (2012). Working memory in multiple sclerosis: a review.Rev. Neurol.16815–27. 10.1016/j.neurol.2011.05.005
10
CaderS.CifelliA.Abu-OmarY.PalaceJ.MatthewsP. M. (2006). Reduced brain functional reserve and altered functional connectivity in patients with multiple sclerosis.Brain 129(Pt 2), 527–537. 10.1093/brain/awh670
11
CalabreseM.RinaldiF.GrossiP.MattisiI.BernardiV.FavarettoA.et al (2010). Basal ganglia and frontal/parietal cortical atrophy is associated with fatigue in relaping-remitting multiple sclerosis.Mult. Scler.161220–1228. 10.1177/1352458510376405
12
ChaudhuriA.BehanP. O. (2000). Fatigue and basal ganglia.J. Neurol. Sci.17934–42. 10.1016/S0022-510X(00)00411-1
13
ChaudhuriA.BehanP. O. (2004). Fatigue in neurological disorders.Lancet363978–98810.1016/S0140-6736(04)15794-2
14
Claros-SalinasD.DittmerN.NeumannM.SehleA.SpiteriS.WillmesK.et al (2013). Induction of cognitive fatigue in MS patients through cognitive and physical load.Neuropychol. Rehabil.23182–201. 10.1080/09602011.2012.726925
15
ColoradoR. A.ShuklaK.ZhouY.WolinskyJ. S.NarayanaP. A. (2012). Multi-task functional MRI in multiple sclerosis patients without clinical disability.Neuroimage59573–581. 10.1016/j.neuroimage.2011.07.065
16
ComiG.LeocaniL.RossiP.ColomboB. (2001). Physiopathology and treatment of fatigue in multiple sclerosis.J. Neurol.248174–17910.1007/s004150170222
17
CôtéI.TrojanD.KaminskaM.CardosoM.BenedettiA.WeissD.et al (2012). Impact of sleep disorder treatment on fatigue in multiple sclerosis.Mult. Scler.19480–48910.1177/1352458512455958
18
Cruz GómezÁ. J.Ventura CamposN.BelenguerA.ÁvilaC.FornC. (2013). Regional brain atrophy and functional connectivity changes related to fatigue in multiple sclerosis.PLoS One8:e77914. 10.1371/journal.pone.0077914
19
Dang-VuT. T.DesseillesM.PeigneuxP.MaquetP. (2006). A role for sleep in brain plasticity.Pediatr. Rehabil.998–118. 10.1080/13638490500138702
20
DasA.WylieG.GenovaH. M.SumowskiJ.DeLucaJ.ChiaravallotiN. (2014). Cognitive reserve modifies the brain network underlying cognitive fatigue in multiple sclerosis (MS).Neurology78:P03.076
21
DeLucaJ.GenovaH. M.HillaryF. G.WylieG. (2008). Neural correlates of cognitive fatigue in multiple sclerosis using functional MRI.J. Neurol. Sci.27028–39. 10.1016/j.jns.2008.01.018
22
DobryakovaE.GenovaH. M.DeLucaJ.WylieG. R. (2015). The dopamine imbalance hypothesis of fatigue in multiple sclerosis and other neurological disorders.Front. Neurol.6:52. 10.3389/fneur.2015.00052
23
FilippiM.RoccaM. A.ColomboB.FaliniA.CodellaM.ScottiG.ComiG. (2002). Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis.Neuroimage15559–567. 10.1006/nimg.2001.1011
24
FornC.Barros-LoscertalesA.EscuderoJ.BellochV.CamposS.ParcetM. A.et al (2006). Cortical reorganization during PASAT task in MS patients with preserved working memory functions.Neuroimage31686–691. 10.1016/j.neuroimage.2005.12.030
25
FritzC. O.MorrisP. E.RichlerJ. J. (2012). Effect size estimates: current use, calculations, and interpretation.J. Exp. Psychol. Gen.1412–18. 10.1037/a0024338
26
GaudinoE. A.GeislerM. W.SquiresN. K. (1995). Construct validity in the trail making test: what makes part B harder?J. Clin. Exp. Neuropychol.17529–535. 10.1080/01688639508405143
27
GenovaH. M.RajagopalanV.DelucaJ.DasA.BinderA.ArjunanA.et al (2013). Examination of cognitive fatigue in multiple sclerosis using functional magnetic resonance imaging and diffusion tensor imaging.PLoS One8:e78811. 10.1371/journal.pone.0078811
28
GronwallD. M. (1977). Paced auditory serial-addition task: a measure of recovery from concussion.Percept. Mot. Skills44367–373. 10.2466/pms.1977.44.2.367
29
Guerrero-MosqueraC.BorragánG.PeigneuxP. (2016). Automatic detection of noisy channels in fNIRS signal based on correlation analysis.J. Neurosci. Methods271128–138. 10.1016/j.jneumeth.2016.07.010
30
GuiD.XuS.ZhuS.FangZ.SpaethA. M.XinY.et al (2015). Resting spontaneous activity in the default mode network predicts performance decline during prolonged attention workload.Neuroimage120323–330. 10.1016/j.neuroimage.2015.07.030
31
HeesenC.NawrathL.ReichC.BauerN.SchulzK. -H.GoldS. M. (2006). Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?J. Neurol. Neurosurg. Pychiatry7734–39. 10.1136/jnnp.2005.065805
32
HuppertT. J.DiamondS. G.FranceschiniM. A.BoasD. A. (2009). HomER: a review of time-series analysis methods for near-infrared spectroscopy of the brain.Appl. Opt.48D280–D298. 10.1364/AO.48.00D280
33
IberC.Ancoli-IsrealS.ChessonA.QuanS. F. (2007). The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology, and Technical Specifications.Darien, IL: American Academy of Sleep Medicine.
34
InduruwaI.ConstantinescuC. S.GranB. (2012). Fatigue in multiple sclerosis - a brief review.J. Neurol. Sci.3239–15. 10.1016/j.jns.2012.08.007
35
KaminskaM.KimoffR. J.SchwartzmanK.TrojanD. A. (2011). Sleep disorders and fatigue in multiple sclerosis: evidence for association and interaction.J. Neurol. Sci.3027–13. 10.1016/j.jns.2010.12.008
36
KirchnerW. K. (1958). Age differences in short-term retention of rapidly changing information.J. Exp. Pychol.55352–358. 10.1037/h0043688
37
KosD.KerckhofsE.NagelsG.D’hoogheM. B.IlsbroukxS. (2008). Origin of fatigue in multiple sclerosis: review of the literature.Neurorehabil. Neural Repair2291–100. 10.1177/1545968306298934
38
KruppL. B.ElkinsL. E. (2000). Fatigue and declines in cognitive functioning in multiple sclerosis.Neurology55934–939. 10.1212/WNL.55.7.934
39
KruppL. B.LaRoccaN. G.Muir-NashJ.SteinbergA. D. (1989). The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus.Arch. Neurol.461121–1123. 10.1001/archneur.1989.00520460115022
40
KurtzkeJ. F. (1983). Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).Neurology331444–1452. 10.1212/WNL.33.11.1444
41
LamersM. J. M.RoelofsA.Rabeling-KeusI. M. (2010). Selective attention and response set in the Stroop task.Mem. Cogn.38893–904. 10.3758/MC.38.7.893
42
LeeK. A.HicksG.Nino-MurciaG. (1991). Validity and reliability of a scale to assess fatigue.Pychiatry Res.36291–298. 10.1016/0165-1781(91)90027-M
43
LehmannP.ElingP.KastrupA.GrothuesO.HildebrandtH. (2012). Self-reported sleep problems, but not fatigue, lead to decline in sustained attention in MS patients.Mult. Scler.19490–49710.1177/1352458512457719
44
LeocaniL.ColomboB.ComiG. (2008). Physiopathology of fatigue in multiple sclerosis.Neurol. Sci.29(Suppl. 2), S241–S243. 10.1007/s10072-008-0950-1
45
lriarteJ.SubiráM. L.de CastroP. (2000). Modalities of fatigue in multiple sclerosis: correlation with clinical and biological factors.Mult. Scler. J.6124–130. 10.1177/135245850000600212
46
McDonaldW. I.ComptonA.EdanG.GoodkinD.HartungH. P.LublinF. D.et al (2001). Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis.Ann. Neurol.50121–127. 10.1002/ana.1032
47
NeuD.MairesseO.VerbanckP.LinkowskiP.Le BonO. (2014). Non-REM sleep EEG power distribution in fatigue and sleepiness.J. Pychosom. Res.76286–291. 10.1016/j.jpsychores.2014.02.002
48
PantanoP. (2002). Contribution of corticospinal tract damage to cortical motor reorganization after a single clinical attack of multiple sclerosis.Neuroimage171837–1843. 10.1006/nimg.2002.1313
49
PennerI. K.RaselliC.StöcklinM.OpwisK.KapposL.CalabreseP. (2009). The Fatigue Scale for Motor and Cognitive Functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue.Mult. Scler.151509–1517. 10.1177/1352458509348519
50
Pittion-VouyovitchS.DebouverieM.GuilleminF.VandenbergheN.AnxionnatR.VespignaniH. (2006). Fatigue in multiple sclerosis is related to disability, depression and quality of life.J. Neurol. Sci.24339–45. 10.1016/j.jns.2005.11.025
51
ReitanR. (1958). Validity of the trail making test as an indicator of organic brain damage.Percept. Mot. Skills8271–276. 10.2466/pms.1958.8.3.271
52
RoelckeU.KapposL.Lechner-ScottJ.BrunnschweilerH.HuberS.AmmannW.et al (1997). Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study.Neurology481566–1571. 10.1212/WNL.48.6.1566
53
RosatiG. (2001). The prevalence of multiple sclerosis in the world: an update.Neurol. Sci.22117–139. 10.1007/s100720170011
54
RudickR.AntelJ.ConfavreuxC.CutterG.EllisonG.FischerJ.et al (1997). Recommendations from the national multiple sclerosis society clinical outcomes assessment task force.Ann. Neurol.42379–382. 10.1002/ana.410420318
55
SandryJ.GenovaH. M.DobryakovaE.DelucaJ.WylieG.MarieO.et al (2014). Subjective cognitive fatigue in multiple sclerosis depends on task length,Front. Neurol.5:214. 10.3389/fneur.2014.00214
56
SanoM.SanoS.OkaN.YoshinoK.KatoT. (2013). Increased oxygen load in the prefrontal cortex from mouth breathing: a vectorbased near-infrared spectroscopy study.Neuroreport24935–940. 10.1097/WNR.0000000000000008
57
SepulcreJ.MasdeuJ. C.GoñiJ.ArrondoG.Vélez de MendizábalN.BejaranoB.et al (2009). Fatigue in multiple sclerosis is associated with the disruption of frontal and parietal pathways.Mult. Scler.15337–344. 10.1177/1352458508098373
58
SmithA. (1968). The symbol-digit modalities test: a neuropychologic test for economic screening of learning and other cerebral disorders.Learn. Disord.383–91.
59
StroberL. B.ArnettP. A. (2005). An examination of four models predicting fatigue in multiple sclerosis.Arch. Clin. Neuropychol.20631–646. 10.1016/j.acn.2005.04.002
60
StroopJ. R. (1935). Studies of interference in serial verbal reactions.J. Exp. Pychol.18643–662. 10.1037/h0054651
61
TomassiniV.Johansen-BergH.JbabdiS.WiseR. G.PozzilliC.PalaceJ.et al (2012). Relating brain damage to brain plasticity in patients with multiple sclerosis.Neurorehabil. Neural Repair.26581–593. 10.1177/1545968311433208
62
TononiG.CirelliC. (2014). Sleep and the price of plasticity: from synaptic and cellular homeostasis to memory consolidation and integration.Neuron8112–34. 10.1016/j.neuron.2013.12.025
63
TrappB. D.PetersonJ. W.RansohoffR. M.RudickR. A.MorkS.BoL.et al (1998). Axonal transection in the lesions of multiple sclerosis.N. Engl. J. Med.338278–285. 10.1056/NEJM199801293380502
64
UrbanekC.Weinges-EversN.Bellmann-StroblJ.BockM.DörrJ.HahnE.et al (2010). Attention Network Test reveals alerting network dysfunction in multiple sclerosis.Mult. Scler.1693–99. 10.1177/1352458509350308
65
VeauthierC.PaulF. (2014). Sleep disorders in multiple sclerosis and their relationship to fatigue.Sleep Med.155–14. 10.1016/j.sleep.2013.08.791
66
VeauthierC.RadbruchH.GaedeG.PfuellerC. F.DörrJ.Bellmann-StroblJ.et al (2011). Fatigue in multiple sclerosis is closely related to sleep disorders: a polysomnographic cross-sectional study.Mult. Scler.17613–622. 10.1177/1352458510393772
67
WalkerL. A.BerardJ. A.BerriganL. I.ReesL. M.FreedmanM. S. (2012). Detecting cognitive fatigue in multiple sclerosis: method matters.J. Neurol. Sci.31686–92. 10.1016/j.jns.2012.01.021
68
WechslerD. (1981). Manual for the Wechsler Adult Intelligence Scale - Revised.New York, NY: Pychological Corporation.
69
WerringD. J.BullmoreE. T.ToosyA. T.MillerD. H.BarkerG. J.MacManusD. G.et al (2000). Recovery from optic neuritis is associated with a change in the distribution of cerebral response to visual stimulation: a functional magnetic resonance imaging study.J. Neurol. Neurosurg. Pychiatry68441–449. 10.1136/jnnp.68.4.441
70
WylieG. R.GenovaH. M.DeLucaJ.DobryakovaE. (2017). The relationship between outcome prediction and cognitive fatigue: a convergence of paradigms.Cogn. Affect. Behav. Neurosci.17838–849. 10.3758/s13415-017-0515-y
71
YoshinoK.OkaN.YamamotoK.TakahashiH.KatoT. (2013). Correlation of prefrontal cortical activation with changing vehicle speeds in actual driving: a vector-based functional near-infrared spectroscopy study.Front. Hum. Neurosci.7:895. 10.3389/fnhum.2013.00895 10.3389/fnhum.2013.00895
72
Yu-FengZ.YongH.Chao-ZheZ.Qing-JiuC.Man-QiuS.MengL.et al (2007). Altered baseline brain activity in children with ADHD revealed by resting-state functional MRI.Brain Dev.2983–91. 10.1016/j.braindev.2006.07.002
Summary
Keywords
cognitive fatigue, sleep, cortical activity, multiple sclerosis, fNRS
Citation
Borragán G, Gilson M, Atas A, Slama H, Lysandropoulos A, De Schepper M and Peigneux P (2018) Cognitive Fatigue, Sleep and Cortical Activity in Multiple Sclerosis Disease. A Behavioral, Polysomnographic and Functional Near-Infrared Spectroscopy Investigation. Front. Hum. Neurosci. 12:378. doi: 10.3389/fnhum.2018.00378
Received
28 February 2018
Accepted
03 September 2018
Published
20 September 2018
Volume
12 - 2018
Edited by
Stephane Perrey, Université de Montpellier, France
Reviewed by
Muthuraman Muthuraman, Universität Mainz, Germany; Makii Muthalib, Université de Montpellier, France
Updates

Check for updates
Copyright
© 2018 Borragán, Gilson, Atas, Slama, Lysandropoulos, De Schepper and Peigneux.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Guillermo Borragán, gborraganpedraz@gmail.com
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.